Journal of Diabetes Investigation (Nov 2019)

Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes

  • Richard J MacIsaac,
  • Matthew Farag,
  • Varuni Obeyesekere,
  • Michele Clarke,
  • Ray Boston,
  • Glenn M Ward,
  • George Jerums,
  • Elif I Ekinci

DOI
https://doi.org/10.1111/jdi.13061
Journal volume & issue
Vol. 10, no. 6
pp. 1537 – 1542

Abstract

Read online

Abstract The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values increased (2,595 ± 683 vs 3,596 ± 1,203 pg/mL, P < 0.001) as eGFR decreased (89 ± 1 vs 51 ± 2 mL/min/1.73m2, P < 0.001) over an 8‐year period. In contrast, there were no significant changes in soluble TNFR1 levels in patients with stable renal function (n = 17). In a multilevel mixed effects regression model, changes in soluble TNFR1 levels were found to be independently associated with eGFR decline (Z = −4.31, P < 0.001). An early decline in eGFR is associated with an increase in soluble TNFR levels; however, the factors driving this increase and the possible pathological role that soluble TNFR1 plays in progressive diabetic kidney disease remain to be determined.

Keywords